A method and application for promoting myogenic differentiation of bovine skeletal muscle satellite cells by interfering with HNRNPR expression

By reducing the expression level of HNRNPR and using siRNA to transfect bovine skeletal muscle satellite cells, the problem of differentiation and regulation of bovine skeletal muscle satellite cells was solved, and effective regulation of the differentiation process of bovine muscle development was achieved, providing new improvements in beef quality and rapid cultivation. Theoretical basis of variety.

CN115976030BActive Publication Date: 2024-11-05TIANJIN AGRICULTURE COLLEGE
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202210792822.2
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-07-07
Publication Date
2024-11-05
Estimated Expiration
2042-07-07

AI Technical Summary

Technical Problem

In the prior art, the mechanism of myogenetic differentiation and regulation of bovine skeletal muscle satellite cells has not been fully understood, and the role of HNRNPR in skeletal muscle development research has been rarely reported, and it is difficult to effectively promote myogenetic differentiation of bovine skeletal muscle satellite cells.

Method used

By designing siRNA for synthesizing HNRNPR, transfecting bovine skeletal muscle satellite cells, reducing the expression level of HNRNPR, thereby promoting myogenic differentiation of bovine skeletal muscle satellite cells, plasmids, viral vectors or gene knockout methods that interfere with HNRNPR expression are used.

Benefits of technology

Effectively regulating the proliferation and myogenetic differentiation process of bovine muscle satellite cells provides insights to study the differentiation mechanism of muscle development, improve beef yield and quality, and provide new ideas and methods for muscle development and damage repair.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN115976030B_ABST
    Figure CN115976030B_ABST
Patent Text Reader

Abstract

The present invention belongs to the field of biology, cell and tissue engineering technology, and discloses a method for promoting myogenic differentiation of bovine skeletal muscle satellite cells by interfering with HNRNPR expression, wherein the method is to promote myogenic differentiation of bovine skeletal muscle satellite cells by reducing the expression of HNRNPR; wherein the nucleotide sequence of the HNRNPR gene is: SEQ ID NO.1. The method of the present invention regulates the proliferation and myogenic differentiation process of bovine muscle satellite cells by changing the expression of HNRNPR, which can provide inspiration for the study of muscle development and differentiation process, and provide reference for exploring the mechanism of muscle growth and development, improving the yield and quality of beef, and can lay a good foundation for further studying the mechanism of action of key hnRNPs proteins in the muscle development process, and provide a theoretical basis for the rapid cultivation of new high-quality beef cattle breeds and meat quality improvement.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the fields of biotechnology, cell and tissue engineering technology, and in particular to a method and application of promoting myogenic differentiation of bovine skeletal muscle satellite cells by interfering with HNRNPR expression. Background Art

[0002] Muscle growth and development involves a series of complex processes such as proliferation, migration, differentiation and fusion of muscle cells, which are regulated by a variety of transcription factors and epigenetic regulatory factors in the form of signal pathways. Skeletal muscle satellite cells are flat cells with protrusions that exist between skeletal muscle fibers and the basement membrane. They are usually in a quiescent state. When they are activated by certain stimuli, they proliferate and differentiate into myoblasts, and eventually form skeletal muscle cells. Satellite cells have always been considered to be stem cells for normal muscle growth and injury repair. Under pathological conditions or when the basement membrane is ruptured or interrupted after muscle cells are traumatized, muscle satellite cells can repair damaged muscle cells by proliferation and differentiation. The in vitro myogenic differentiation process of muscle satellite cells can well simulate the in vivo muscle development process and is a good cell model for studying cell differentiation and muscle development. The activation, proliferation and myogenic differentiation process of muscle satellite cells are regulated by a variety of factors, and the specific mechanism of action of many key regulatory factors is still unknown. Understanding the myogenic differentiation regulation mode of skeletal muscle satellite cells can increase the possibility of artificially controlling muscle cell formation.

[0003] Heterogeneous nuclear ribonucleoproteins (hnRNPs) are a superfamily of proteins that participate in a variety of important life activities. There are more than 20 members in the family, and their molecular sizes and isoelectric points vary, ranging from 34 to 120 kDa. They are named hnRNPA1-U according to their molecular weights. hnRNPs can bind to pre-mRNA through a specific structure to form a complex, and participate in physiological processes such as mRNA transport, splicing and expression. The main structural difference between the members of the hnRNPs family lies in the sequence composition of the RNA binding region, so the RNA binding region is the main factor that determines the functional specificity of the protein. hnRNPs can bind to the non-coding region of the messenger RNA through its RNA binding region, and play an important role in cell nucleic acid metabolism, alternative splicing, regulation of telomerase activity, DNA damage repair, and stabilization of mRNA. HNRNPR was initially identified as a member of the hnRNP family. HNRNPR has multiple functions in vivo, such as regulating splicing, RNA transport and RNA stability, and can also regulate the transcription process of pre-mRNA and mature mRNA. HNRNPR can promote the proliferation ability, migration ability and invasion ability of various cancer cells. When HNRNPR is knocked out in the mouse model, the invasiveness and metastasis of the tumor can be reduced. However, there are few reports on the study of HNRNPR's involvement in animal skeletal muscle development. Based on this, the present invention uses a bovine skeletal muscle satellite cell in vitro induced myogenic differentiation model, and by interfering with the expression of HNRNPR in bovine skeletal muscle satellite cells, the effect of HNRNPR on the in vitro myogenic differentiation of bovine skeletal muscle satellite cells is studied, laying a certain foundation for further exploring genes that affect bovine muscle development.

[0004] Through searching, no patent publication documents related to the patent application of the present invention have been found. Summary of the invention

[0005] The purpose of the present invention is to overcome the deficiencies in the prior art and provide a method and application for promoting myogenic differentiation of bovine skeletal muscle satellite cells by interfering with HNRNPR expression.

[0006] The technical solution adopted by the present invention to solve its technical problem is:

[0007] A method for promoting myogenic differentiation of bovine skeletal muscle satellite cells by interfering with HNRNPR expression, wherein the method promotes myogenic differentiation of bovine skeletal muscle satellite cells by reducing the expression of HNRNPR; wherein the nucleotide sequence of the HNRNPR gene is: SEQ ID NO.1.

[0008] Further, the following steps are included:

[0009] According to the genomic base sequence of HNRNPR, siRNA of HNRNPR was designed and synthesized, and bovine skeletal muscle satellite cells were transfected with siRNA to reduce the expression level of HNRNPR, thereby promoting the myogenic differentiation of bovine skeletal muscle satellite cells.

[0010] Furthermore, the sequence of the siRNA is: SEQ ID NO.2.

[0011] Furthermore, the method of interfering with the expression level of HNRNPR includes: using a plasmid, a viral vector or gene knockout that interferes with the expression of HNRNPR.

[0012] Application of the method for promoting myogenic differentiation of bovine skeletal muscle satellite cells by interfering with HNRNPR expression as described above in the proliferation and myogenic differentiation of bovine muscle satellite cells.

[0013] The advantages and positive effects achieved by the present invention are:

[0014] 1. The method of the present invention regulates the proliferation and myogenic differentiation process of bovine muscle satellite cells by changing the expression of HNRNPR, which can provide inspiration for the study of muscle development and differentiation process, and provide a reference for exploring the mechanism of muscle growth and development and improving the yield and quality of beef. It can lay a good foundation for further research on the mechanism of action of key hnRNPs proteins in the muscle development process, and provide a theoretical basis for the rapid breeding of new high-quality beef cattle breeds and the improvement of meat quality.

[0015] 2. The method established by the present invention for promoting the proliferation and myogenic differentiation of bovine skeletal muscle satellite cells by changing the expression of HNRNPR can effectively regulate the muscle development and differentiation process. This method can provide a certain reference for the use of HNRNPR in muscle development, differentiation and injury repair, and provide new ideas and references for the clinical research and diagnosis and treatment of muscle development, differentiation and injury repair.

[0016] 3. In view of the fact that it is still unclear whether HNRNPR has a certain regulatory effect on bovine skeletal muscle satellite cells and the specific effect, the present invention designs and synthesizes HNRNPR siRNA, and then uses lip3000 reagent to transfect bovine skeletal muscle satellite cells, interferes with the expression level of HNRNPR in bovine skeletal muscle satellite cells, and promotes the proliferation and myogenic differentiation of bovine skeletal muscle satellite cells by changing the expression of HNRNPR in bovine skeletal muscle satellite cells. This method can provide a reference for the use of HNRNPR in muscle development, differentiation and injury repair, and provide new ideas and methods for clinical research and diagnosis and treatment of muscle development, differentiation and injury repair.

[0017] 4. The method of the present invention utilizes HNRNPR to regulate the proliferation and myogenic differentiation of bovine muscle satellite cells, which can provide inspiration for the study of muscle development and differentiation process, and provide a reference for exploring the mechanism of muscle growth and development and improving the yield and quality of beef. BRIEF DESCRIPTION OF THE DRAWINGS

[0018] Figure 1 The figure is a quantitative PCR detection result diagram of the expression level change of HNRNPR in different stages of myogenic differentiation of bovine skeletal muscle satellite cells in the present invention; wherein GM is the proliferation stage of bovine skeletal muscle satellite cells, DM1 is the first day of differentiation of bovine skeletal muscle satellite cells, DM2 is the second day of differentiation of bovine skeletal muscle satellite cells, and DM3 is the third day of differentiation of bovine skeletal muscle satellite cells;

[0019] Figure 2 This is a diagram showing the interference effect of using siRNA to interfere with HNRNPR in the present invention;

[0020] Figure 3 This is a diagram showing the qRT-PCR detection results of the differentiation marker genes MyoG and MyHC in bovine skeletal muscle satellite cells by using siRNA to interfere with HNRNPR expression in the present invention;

[0021] Figure 4 The figure is a Western blot detection result of the differentiation marker gene MyHC in bovine skeletal muscle satellite cells using siRNA to interfere with HNRNPR expression in the present invention; wherein A is a Western blot detection of MyHC protein expression level after interference, and B is a visual schematic diagram of Western blot detection. DETAILED DESCRIPTION

[0022] The embodiments of the present invention are described in detail below. It should be noted that the embodiments are descriptive rather than restrictive and cannot be used to limit the protection scope of the present invention.

[0023] The raw materials used in the present invention, unless otherwise specified, are conventional commercially available products; the methods used in the present invention, unless otherwise specified, are conventional methods in the art.

[0024] A method for promoting myogenic differentiation of bovine skeletal muscle satellite cells by interfering with HNRNPR expression, wherein the method promotes myogenic differentiation of bovine skeletal muscle satellite cells by reducing the expression of HNRNPR; wherein the nucleotide sequence of the HNRNPR gene is: SEQ ID NO.1.

[0025] Preferably, the method comprises the following steps:

[0026] According to the genomic base sequence of HNRNPR, siRNA of HNRNPR was designed and synthesized, and bovine skeletal muscle satellite cells were transfected with siRNA to reduce the expression level of HNRNPR, thereby promoting the myogenic differentiation of bovine skeletal muscle satellite cells.

[0027] Preferably, the sequence of the siRNA is: SEQ ID NO.2.

[0028] Preferably, the method of interfering with the expression level of HNRNPR comprises: using a plasmid, a viral vector or gene knockout that interferes with the expression of HNRNPR.

[0029] Application of the method for promoting myogenic differentiation of bovine skeletal muscle satellite cells by interfering with HNRNPR expression as described above in the proliferation and myogenic differentiation of bovine muscle satellite cells.

[0030] Specifically, the relevant preparation and detection examples are as follows:

[0031] A design idea of ​​the present invention may be:

[0032] The siRNA of HNRNPR was designed and synthesized, and then the bovine skeletal muscle satellite cells were transfected with lip3000 reagent to interfere with the expression level of HNRNPR in the bovine skeletal muscle satellite cells. By changing the expression of HNRNPR in the bovine skeletal muscle satellite cells, the myogenic differentiation process of the bovine skeletal muscle satellite cells was promoted.

[0033] A method for promoting myogenic differentiation of bovine skeletal muscle satellite cells by interfering with HNRNPR expression, comprising the following steps:

[0034] Step 1: Isolation and culture of bovine skeletal muscle satellite cells, establishment of an in vitro myogenic differentiation model, and detection of the temporal expression of HNRNPR in myogenic differentiation of muscle satellite cells:

[0035] Bovine skeletal muscle satellite cells were isolated by combined digestion with trypsin and collagenase, and an in vitro myogenic differentiation model of bovine skeletal muscle satellite cells was established. Quantitative PCR and Western blot were used to detect the expression of HNRNPR in bovine skeletal muscle satellite cells before and after myogenic differentiation.

[0036] The specific steps are as follows:

[0037] (1) Isolation and culture of bovine skeletal muscle satellite cells and establishment of an in vitro myogenic differentiation model.

[0038] Bovine skeletal muscle satellite cells were isolated by combined digestion with trypsin and collagenase. Bovine fetal hind limb muscles were collected under sterile conditions, cut into appropriate sizes, washed several times in PBS buffer, and fully minced with ophthalmic scissors in a culture dish. After rinsing once with preheated PBS buffer, centrifuged at 1000r / min for 5 minutes in a centrifuge, the supernatant was discarded, 5ml of 0.2% collagenase II was added, and digested in a 37℃ water bath for 1h. During this period, vortex oscillation was performed for 10s every 10min, and then 0.25% trypsin containing EDTA was added for digestion for 30min. During this period, Vortex and oscillate for 10s every 10min, and finally add medium containing 20% ​​fetal bovine serum (20% FBS + 80% DMEM) to terminate digestion. The above mixture is passed through 100 mesh, 200 mesh and 400 mesh cell sieves in turn, and the filtrate is collected in a 50ml centrifuge tube, centrifuged at 1000r / min for 10min in a centrifuge, resuspended with medium (20% FBS + 80% DMEM), inoculated into a suitable culture dish, and cultured in a 37°C, 5% CO2 incubator. Cultured in DMEM growth medium containing 20% ​​fetal bovine serum, when the cells grow to 80% confluence, add DMEM differentiation medium containing 2% horse serum for in vitro myogenic differentiation, observe the differentiation of muscle satellite cells and the state of myotube formation, and establish an in vitro myogenic differentiation model of bovine skeletal muscle satellite cells.

[0039] (2) Genomic base sequence of HNRNPR (2602 bp): SEQ NO.1.

[0040]

[0041] (3) Detection of the expression changes of HNRNPR during different stages of myogenic differentiation of bovine skeletal muscle satellite cells.

[0042] Total RNA of proliferating and differentiated cells was extracted using a cell RNA rapid extraction kit. Extraction steps: Add 600mL of cell lysis buffer to a 24-well cell culture plate and repeatedly pipette until the cells are fully lysed. After observing that the cells are completely lysed under a microscope, collect the above lysate into a 1.5mL RNase-free tube. Add all the lysis mixture to the DNA cleanup column. Immediately centrifuge at 13,000rpm for 60s. Use a micropipette to accurately estimate the volume of the filtrate, add an equal volume of 70% ethanol, and immediately pipette to mix, without centrifugation. Immediately add the mixture to an adsorption column RA, centrifuge at 13,000rpm for 30s, and discard the waste liquid. Add 700μL of deproteinization solution RW1, leave at room temperature for 1 minute, centrifuge at 12,000rpm for 30s, and discard the waste liquid. Add 500mL of rinsing solution RW, centrifuge at 12,000rpm for 30s, and discard the waste liquid. Add 500mL of rinsing solution RW and repeat. Put the adsorption column RA back into the empty collection, centrifuge at 13000rpm for 2 minutes, and try to remove the rinse solution to prevent the residual ethanol in the rinse solution from inhibiting the downstream reaction. Take out the adsorption column RA and put it into an enzyme-free centrifuge tube. Add 30-50mL of enzyme-free water to the middle part of the adsorption membrane according to the expected RNA yield, leave it at room temperature for 1 minute, and centrifuge it at 12000rpm for 1 minute.

[0043] The reverse transcription and quantitative PCR of RNA were performed according to the instructions of the kit. The primer sequences used are shown in Table 1, and GAPDH was used as an internal reference. The reverse transcription and quantitative PCR operating conditions of RNA were as follows:

[0044] ①RNA reverse transcription system and conditions:

[0045]

[0046] Prepare a 20 μL mixed solution.

[0047] Vortex to mix, centrifuge briefly, and collect the solution on the tube wall to the bottom of the PCR tube.

[0048] Place the prepared mixture on the PCR instrument and set the program: incubate at 42°C for 15 minutes, then incubate at 85°C for 5 minutes. After the above program is completed, centrifuge briefly and take out the reverse transcribed cDNA mixture and cool it on ice.

[0049] ②Quantitative PCR detection system:

[0050] Preparation of reaction solution: Prepare the reaction solution on ice. Perform duplicate well experiments and single-well NTC experiments for each sample. Use a white quantitative plate for quantitative PCR detection.

[0051] The reaction solution in each single well of the quantitative plate is configured as follows:

[0052]

[0053] A total of 20 μL reaction system.

[0054] qRT-PCR reaction conditions:

[0055] After the reaction solution is fully mixed, centrifuge it to make the reaction solution reach the bottom of the reaction tube and place it on the real-time fluorescence quantitative PCR instrument. The specific reaction design procedure is as follows:

[0056] Pre-denaturation: 60s at 95℃

[0057] Denaturation: 95℃ for 10s

[0058] Annealing: 20s at 61°C

[0059] Extension: 15s at 72℃

[0060] The denaturation to annealing steps were repeated 35 times.

[0061] After the reaction is completed, a melting curve is drawn. In this experiment, the fluorescence detection temperature range is 65°C-95°C, the heating rate is 0.5°C / cycle, and the constant temperature time is 10s / cycle.

[0062] After all reactions were completed, the tubes were kept at 37°C for 30 seconds to prevent them from being burned when being taken out.

[0063] Table 1 Primer sequences for real-time quantitative PCR of HNRNPR

[0064]

[0065] Quantitative PCR test results are shown in Figure 1 The experimental results showed that with the extension of the differentiation time of bovine skeletal muscle satellite cells, the mRNA expression level of HNRNPR showed a trend of first increasing and then decreasing, and the mRNA expression of HNRNPR was the highest on the first day of differentiation induction, and the mRNA expression level of HNRNPR on the second day of differentiation (DM2) and the third day of differentiation (DM3) was significantly reduced compared with the proliferation period. This shows that HNRNPR may have the role of regulating the myogenic differentiation of bovine skeletal muscle satellite cells.

[0066] Step 2: Establishment of bovine skeletal muscle satellite cell inhibition expression model and detection of interference effect:

[0067] According to the HNRNPR base sequence, siRNA was designed and synthesized, and then transfected into bovine skeletal muscle satellite cells. The expression level of HNRNPR was detected by quantitative PCR, and the interference effect of siRNA on HNRNPR was detected.

[0068] The specific steps are as follows:

[0069] (1) Design and synthesis of HNRNPR interfering RNA (siRNA).

[0070] Based on the HNRNPR base sequence, siRNA (SEQ NO. 2: GGAAGAACCAGATCCAGAA) was designed and synthesized by a biological company.

[0071] (2) Establishment of an inhibitory expression model of bovine skeletal muscle satellite cells.

[0072] HNRNPR siRNA was transfected into bovine skeletal muscle satellite cells using lip 3000 reagent, and the bovine skeletal muscle satellite cells were inoculated in a 24-well cell culture plate and cultured with growth medium. When the cell growth density was 70% to 80%, transfection was prepared, and the medium was replaced with growth medium without antibiotics one day before transfection. According to the concentration recommended in the reagent manual, si-RNA and negative control were transfected at a final concentration of 50nM. When performing transfection, first replace the culture medium with serum-free Opti-MEM culture medium, mix si-RNA or the corresponding negative control in 50 μL Opti-MEM culture medium, and mix 0.75 μL lip3000 transfection reagent in 50 μL Opti-MEM culture medium, and let them stand for 5 minutes respectively. Add the Opti-MEM culture medium containing siRNA or the corresponding negative control to the Opti-MEM culture medium containing Roche transfection reagent, mix gently and let the mixture stand for 15 minutes, and evenly add the mixture dropwise to a 24-well cell culture plate. The volume of the added mixture should be based on the final concentration of siRNA or the corresponding negative control.

[0073] (3) Detection of siRNA interference effect.

[0074] 24 hours after transfection, the culture medium was replaced with myogenic differentiation medium and continued to be cultured to induce differentiation of muscle satellite cells. At 24 hours after transfection and 48 hours after differentiation, the total RNA of transfected cells in the 24-well plate was extracted using a cell RNA rapid extraction kit, and the mRNA expression level of HNRNPR was detected by quantitative PCR. The total RNA extraction, RNA reverse transcription and quantitative PCR operations were the same as in the first step. The primer sequences used are shown in Table 1, and the test results are shown in Figure 2The experimental results showed that siRNA had a significant interference effect on the expression of HNRNPR and significantly reduced the expression level of HNRNPR (**, p<0.01 compared with the control NC), which can be used for subsequent HNRNPR expression regulation studies.

[0075] Step 3: Effect of interfering with HNRNPR on myogenic differentiation of bovine skeletal muscle satellite cells:

[0076] Bovine skeletal muscle satellite cells were transfected with siRNA to interfere with the expression of HNRNPR, and then the muscle satellite cells were induced to differentiate into myogenic cells. The expression of differentiation marker genes MyoG and MyHC was examined by quantitative PCR and Western blot to determine the effect of interfering with HNRNPR expression on the myogenic differentiation of bovine muscle satellite cells.

[0077] The specific steps are:

[0078] HNRNPR siRNA was transfected into bovine skeletal muscle satellite cells using lip3000 reagent. The specific operation was the same as the siRNA transfection method in the second step. 24 hours after transfection, the culture medium was replaced with myogenic differentiation medium and culture was continued to induce differentiation of muscle satellite cells. Quantitative PCR was used to test the mRNA expression of differentiation marker genes MyoG and MyHC. The primer sequences used are shown in Table 2. GAPDH was used as an internal reference, and the sequence was the same as Table 1. The results showed that the mRNA expression levels of differentiation marker factors MyoG and MyHC were significantly increased after interfering with HNRNPR. The test results are shown in Table 2. Figure 3 (**, p<0.01 compared to control NC).

[0079] Table 2 Primer sequences for real-time quantitative PCR of differentiation marker genes MyoG and MyHC

[0080]

[0081] Extract the protein of the proliferating and differentiated bovine skeletal muscle satellite cells. The extraction steps are as follows: discard the culture medium, add pre-cooled PBS to wash the cells. Taking a 6-well plate as an example, add 200 μL of RIPA lysis buffer containing 1% PMSF to each well of the bovine skeletal muscle satellite cells, the dilution ratio is 100:1, lyse at 4°C for 15 minutes, and collect into a 1.5mL enzyme-free centrifuge tube. Under 4°C conditions, high-speed centrifuge 12000×g10min, transfer the supernatant to a 1.5mL enzyme-free centrifuge tube, and store the protein sample at -20°C. The protein concentration was measured by the BCA method, and the protein was diluted with 4× protein loading buffer to ensure that the protein loading amount of all samples was the same, and denatured in boiling water at 100°C for 10 minutes. Then perform Western blot detection, configure 10% concentrated gel and separation gel, then spot, electrophoresis at 80V constant voltage for 40 minutes, and after the protein reaches the separation gel, electrophoresis at 120V constant voltage for 90 minutes. The concentrated gel was removed, and the gel was clamped to the PVDF membrane. The membrane was transferred at a constant current of 300 mA for 2 hours. After the transfer, it was blocked with 5% skim milk powder for 2 hours. The membrane was washed with TBST 3 times, 10 minutes each time. The final dilution of the HNRNPR primary antibody was 1:500, and the final dilution of the MyHC, MyoG, and Pax7 primary antibodies was 0.5μg / mL; the dilution of the Tubulin primary antibody was 1:3000. The membrane and the primary antibody were sealed in the hybridization bag and incubated overnight at 4°C. The membrane was washed with TBST 3 times, 10 minutes each time. The dilution multiple of the goat anti-mouse secondary antibody and the goat anti-rabbit secondary antibody was 1:20000, and the PVDF was incubated in the secondary antibody diluent at room temperature for 1 hour. The membrane was washed with TBST 3 times, 10 minutes each time. Add 200μL of ECL supersensitive luminescent solution to the PVDF membrane and use ChemiDoc TM Imaging System imaging and storage.

[0082] Western blot was used to test the protein expression of differentiation marker gene MyHC. The results showed that the protein expression level of differentiation marker factor MyHC increased significantly after interfering with HNRNPR. The test results are shown in Figure 4 (*, p<0.05 compared with the control NC), indicating that down-regulating HNRNPR can promote the myogenic differentiation of muscle satellite cells. The above research results suggest that changing the expression of HNRNPR related to muscle development and differentiation in bovine skeletal muscle satellite cells can affect the myogenic differentiation process of bovine skeletal muscle satellite cells.

[0083] Of course, methods for changing the expression level of HNRNPR include designing synthetic interfering RNA (siRNA), as well as plasmids, viral vectors and gene knockout that interfere with the expression of HNRNPR and other means that can change the expression level of HNRNPR.

[0084] Although the embodiments of the present invention are disclosed for illustrative purposes, those skilled in the art will appreciate that various substitutions, changes and modifications are possible without departing from the spirit and scope of the present invention and the appended claims. Therefore, the scope of the present invention is not limited to the contents disclosed in the embodiments.

Claims

1. A method for promoting myogenic differentiation of bovine skeletal muscle satellite cells by interfering with HNRNPR expression, characterized in that: The method is to promote the myogenic differentiation of bovine skeletal muscle satellite cells by reducing the expression of HNRNPR; wherein the nucleotide sequence of the HNRNPR gene is: SEQ ID NO.1, and the method is not intended for the diagnosis and treatment of diseases.

2. The method for promoting myogenic differentiation of bovine skeletal muscle satellite cells by interfering with HNRNPR expression according to claim 1, characterized in that: The steps include: According to the genomic base sequence of HNRNPR, siRNA of HNRNPR was designed and synthesized, and bovine skeletal muscle satellite cells were transfected with siRNA to reduce the expression level of HNRNPR, thereby promoting the myogenic differentiation of bovine skeletal muscle satellite cells.

3. The method for promoting myogenic differentiation of bovine skeletal muscle satellite cells by interfering with HNRNPR expression according to claim 2, characterized in that: The sequence of the siRNA is: SEQ ID NO.

2.

4. Use of the method for promoting myogenic differentiation of bovine skeletal muscle satellite cells by interfering with HNRNPR expression as claimed in any one of claims 1 to 3 in the proliferation and myogenic differentiation of bovine muscle satellite cells, wherein the use is not for the purpose of diagnosis and treatment of diseases.